- Home
- PMEC vs IBIO Comparison
PMEC vs IBIO Comparison
Compare PMEC & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- IBIO
- Stock Information
- Founded
- PMEC 1984
- IBIO 2008
- Country
- PMEC Singapore
- IBIO United States
- Employees
- PMEC 2744
- IBIO N/A
- Industry
- PMEC
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- IBIO Health Care
- Exchange
- PMEC Nasdaq
- IBIO Nasdaq
- Market Cap
- PMEC 26.2M
- IBIO 24.3M
- IPO Year
- PMEC 2023
- IBIO N/A
- Fundamental
- Price
- PMEC $0.69
- IBIO $3.48
- Analyst Decision
- PMEC
- IBIO Strong Buy
- Analyst Count
- PMEC 0
- IBIO 3
- Target Price
- PMEC N/A
- IBIO $4.87
- AVG Volume (30 Days)
- PMEC 323.0K
- IBIO 299.1K
- Earning Date
- PMEC 12-31-2024
- IBIO 02-10-2025
- Dividend Yield
- PMEC N/A
- IBIO N/A
- EPS Growth
- PMEC N/A
- IBIO N/A
- EPS
- PMEC N/A
- IBIO N/A
- Revenue
- PMEC $72,524,000.00
- IBIO $375,000.00
- Revenue This Year
- PMEC N/A
- IBIO $36.00
- Revenue Next Year
- PMEC N/A
- IBIO $33.33
- P/E Ratio
- PMEC N/A
- IBIO N/A
- Revenue Growth
- PMEC 5.07
- IBIO 650.00
- 52 Week Low
- PMEC $0.49
- IBIO $1.05
- 52 Week High
- PMEC $4.15
- IBIO $4.98
- Technical
- Relative Strength Index (RSI)
- PMEC 46.18
- IBIO 55.25
- Support Level
- PMEC $0.69
- IBIO $3.22
- Resistance Level
- PMEC $0.74
- IBIO $3.76
- Average True Range (ATR)
- PMEC 0.08
- IBIO 0.38
- MACD
- PMEC -0.00
- IBIO 0.00
- Stochastic Oscillator
- PMEC 6.64
- IBIO 56.41
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.